NPY4R

neuropeptide Y receptor Y4, the group of Neuropeptide Y receptors

Basic information

Region (hg38): 10:46461099-46465958

Previous symbols: [ "PPYR1" ]

Links

ENSG00000204174NCBI:5540OMIM:601790HGNC:9329Uniprot:P50391AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NPY4R gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPY4R gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
3
clinvar
2
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
5
clinvar
5
Total 0 0 3 0 9

Variants in NPY4R

This is a list of pathogenic ClinVar variants found in the NPY4R region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-46461589-T-T Benign (May 14, 2018)768362
10-46461612-G-T not specified Uncertain significance (May 01, 2024)3300886
10-46461654-T-A not specified Uncertain significance (Nov 09, 2021)2260124
10-46461688-A-A Benign (May 14, 2018)768361
10-46461700-C-T not specified Uncertain significance (Oct 04, 2024)3407541
10-46461739-A-A Benign (May 14, 2018)768360
10-46461746-A-G not specified Uncertain significance (Aug 13, 2021)2224094
10-46461765-G-C not specified Uncertain significance (Aug 12, 2024)3407543
10-46461812-G-A not specified Uncertain significance (Dec 04, 2024)3407542
10-46461918-A-G Benign (May 14, 2018)768358
10-46461918-A-A Benign (May 14, 2018)768359
10-46461945-A-A Benign (May 14, 2018)768357
10-46462052-A-C not specified Uncertain significance (Jun 02, 2024)3300885
10-46462166-T-C not specified Uncertain significance (Dec 10, 2024)3407545
10-46462251-T-C not specified Uncertain significance (May 30, 2023)2520310
10-46462271-C-T not specified Uncertain significance (Nov 14, 2024)3407544
10-46462341-C-A Benign (May 14, 2018)768356
10-46462402-C-G Benign (Aug 15, 2017)714452
10-46462504-G-A Benign (May 08, 2018)769368

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NPY4Rprotein_codingprotein_codingENST00000374312 14787
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.21e-70.1731256970491257460.000195
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1391641690.9700.000008972243
Missense in Polyphen4959.3070.82621833
Synonymous-1.809474.31.270.00000436691
Loss of Function-0.17298.461.064.60e-795

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002100.000210
Ashkenazi Jewish0.000.00
East Asian0.0007070.000707
Finnish0.0001390.000139
European (Non-Finnish)0.0001930.000193
Middle Eastern0.0007070.000707
South Asian0.0001630.000163
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is PP, PP (2-36) and [Ile-31, Gln-34] PP > [Pro-34] PYY > PYY and [Leu-31, Pro-34] NPY > NPY > PYY (3-36) and NPY (2-36) > PP (13- 36) > PP (31-36) > NPY free acid.;
Pathway
Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);regulation of eif2;akap95 role in mitosis and chromosome dynamics;GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.119

Intolerance Scores

loftool
rvis_EVS
1.07
rvis_percentile_EVS
91.68

Haploinsufficiency Scores

pHI
0.124
hipred
N
hipred_score
0.219
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Npy4r
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;neuropeptide signaling pathway
Cellular component
plasma membrane;integral component of plasma membrane;membrane
Molecular function
pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding